BioGaia AB (publ) (BIOGY)
BioGaia AB (publ) Statistics
Share Statistics
BioGaia AB (publ) has 99.37M shares outstanding. The number of shares has increased by -4.24% in one year.
| Shares Outstanding | 99.37M |
| Shares Change (YoY) | -4.24% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 79.25M |
| Failed to Deliver (FTD) Shares | 270 |
| FTD / Avg. Volume | 60.67% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 31.82 and the forward PE ratio is null. BioGaia AB (publ)'s PEG ratio is -8.23.
| PE Ratio | 31.82 |
| Forward PE | n/a |
| PS Ratio | 7.86 |
| Forward PS | n/a |
| PB Ratio | 6.49 |
| P/FCF Ratio | 31.14 |
| PEG Ratio | -8.23 |
Enterprise Valuation
BioGaia AB (publ) has an Enterprise Value (EV) of 9.96B.
| EV / Sales | 7 |
| EV / EBITDA | 18.46 |
| EV / EBIT | 26.68 |
| EV / FCF | 27.73 |
Financial Position
The company has a current ratio of 7.81, with a Debt / Equity ratio of 0.
| Current Ratio | 7.81 |
| Quick Ratio | 7.81 |
| Debt / Equity | 0 |
| Debt / EBITDA | 0 |
| Debt / FCF | 0 |
| Interest Coverage | 28.37 |
Financial Efficiency
Return on Equity is 20.38% and Return on Invested Capital is 18.18%.
| Return on Equity | 20.38% |
| Return on Assets | 17.28% |
| Return on Invested Capital | 18.18% |
| Revenue Per Employee | $6.32M |
| Profits Per Employee | $1.56M |
| Employee Count | 225 |
| Asset Turnover | 0.7 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 96.43M |
| Effective Tax Rate | 21.53% |
Stock Price Statistics
The stock price has increased by 11.21% in the last 52 weeks. The beta is 0.71, so BioGaia AB (publ)'s price volatility has been higher than the market average.
| Beta | 0.71 |
| 52-Week Price Change | 11.21% |
| 50-Day Moving Average | 10.16 |
| 200-Day Moving Average | 10.79 |
| Relative Strength Index (RSI) | 69.37 |
| Average Volume (20 Days) | 445 |
Income Statement
In the last 12 months, BioGaia AB (publ) had revenue of 1.42B and earned 351.39M in profits. Earnings per share was 3.48.
| Revenue | 1.42B |
| Gross Profit | 1.03B |
| Operating Income | 423.37M |
| Net Income | 351.39M |
| EBITDA | 539.44M |
| EBIT | 462.74M |
| Earnings Per Share (EPS) | 3.48 |
Balance Sheet
The company has 1.22B in cash and 0 in debt, giving a net cash position of 1.22B.
| Cash & Cash Equivalents | 1.22B |
| Total Debt | 0 |
| Net Cash | 1.22B |
| Retained Earnings | 0 |
| Total Assets | 2.03B |
| Working Capital | 1.4B |
Cash Flow
In the last 12 months, operating cash flow was 373.22M and capital expenditures -14.15M, giving a free cash flow of 359.06M.
| Operating Cash Flow | 373.22M |
| Capital Expenditures | -14.15M |
| Free Cash Flow | 359.06M |
| FCF Per Share | 3.55 |
Margins
Gross margin is 72.45%, with operating and profit margins of 29.76% and 24.7%.
| Gross Margin | 72.45% |
| Operating Margin | 29.76% |
| Pretax Margin | 31.48% |
| Profit Margin | 24.7% |
| EBITDA Margin | 37.92% |
| EBIT Margin | 29.76% |
| FCF Margin | 25.24% |
Dividends & Yields
BIOGY pays an annual dividend of $0.63, which amounts to a dividend yield of 5.52%.
| Dividend Per Share | $0.63 |
| Dividend Yield | 5.52% |
| Dividend Growth (YoY) | 126.33% |
| Payout Ratio | 176.22% |
| Earnings Yield | 3.14% |
| FCF Yield | 3.21% |
Analyst Forecast
Currently there are no analyst rating for BIOGY.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on May 26, 2022. It was a forward split with a ratio of 5:2.
| Last Split Date | May 26, 2022 |
| Split Type | forward |
| Split Ratio | 5:2 |
Scores
| Altman Z-Score | 4.31 |
| Piotroski F-Score | 5 |